DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors Read more about DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases Read more about A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases
ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System Read more about ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough Read more about A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations Read more about Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial) Read more about Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) Read more about A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs Read more about Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA-2 Read more about A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA-2
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers Read more about DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers